Download FREE Report Sample
Download Free sampleFemale contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.
Female Contraceptive Market contains market size and forecasts of Female Contraceptive in global, including the following market information:
Global Female Contraceptive Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Female Contraceptive Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Female Contraceptive companies in 2021 (%)
The global Female Contraceptive market was valued at 18920 million in 2021 and is projected to reach US$ 22510 million by 2028, at a CAGR of 2.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Female Contraceptive Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Female Contraceptive include Merck, Pfizer, Allergan, Bayer, Okamoto Industries, Reckitt Benckiser, Lupin Pharmaceuticals, Foundation Consumer Healthcare and Teva Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Female Contraceptive manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Female Contraceptive Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Female Contraceptive Market Segment Percentages, by Type, 2021 (%)
Female Contraceptive Devices
Female Contraceptive Drugs
Global Female Contraceptive Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Female Contraceptive Market Segment Percentages, by Application, 2021 (%)
Online Stores
Retail Outlets
Global Female Contraceptive Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Female Contraceptive Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Female Contraceptive revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Female Contraceptive revenues share in global market, 2021 (%)
Key companies Female Contraceptive sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Female Contraceptive sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
